16. Oktober 2017
Pharmaboardroom.com interviewed ARCHIMEDlife CEO David Kasper for their latest Austria issue of „Healthcare and Life Sciences Review”. Find out...Read more
26. September 2017
ARCHIMEDlife founder Assoc. Prof. DI DDr. David C. Kasper in an interview about the correct diagnosis of Morbus Fabry...Read more
13. September 2017
We are proud to be a regular part of MSACL – this year in Salzburg from 10.- 14. September...Read more
4. September 2017
You can easily subscribe to our monthly ARCHIMEDlife Newsletter and read about laboratory diagnostics, research studies, scientific publications and...Read more
5. Juli 2017
Background: Fabry disease (FD) is a rare X-linked lysosomal storage disease caused by mutations in the α-galactosidase A (GLA)...Read more
3. Januar 2017
Background: Fabry disease is an X-linked lysosomal storage disorder due to α-galactosidase A (α-Gal A) deficiency. Clinical onset of...Read more
15. Januar 2015
BACKGROUND: We aimed to determine the incidence of primary gestational infections with Toxoplasma gondii and congenital toxoplasmosis in Austria, a...Read more
13. November 2014
In 1966, the National Austrian Newborn Screening Program for inherited metabolic and endocrine disorders was initiated. In the last...Read more
15. Juli 2013
Screening for inborn errors of metabolism using mass spectrometry is part of nationwide newborn screening programs and involves the...Read more
Started in 2013, ARCHIMEDlife is an independent highly-innovative company dedicated in providing and developing diagnostic services from Inborn Errors of Metabolism to Oncological Diseases. Our commitment is to provide better and faster high-quality laboratory tests for you and your family.
Our diagnostic laboratory is offering services from Clinical Mass Spectrometry to Next-Generation Sequencing. We have international collaborations with physicians, clinical researchers and industry specialized in personalized health care.
We are dedicated to the development of novel laboratory tests to to make actionable health information accessible at the time it matters.